From a competitive standpoint, a Zurich-owned ClearView could put pressure on peers to respond with sharper pricing, improved definitions or more adviser support, particularly in segments where ClearView has been active. That could be positive for customers in the near term, but it can also intensify the work required of brokers to compare policy wording, offsets, premium structures and underwriting decisions—especially for complex medical, occupational or financial underwriting cases.